Shares of Thermo Fisher Scientific Inc. TMO slid 1.16% to $533.29 Wednesday, on what proved to be an all-around mixed trading ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective registry ...
22h
Hosted on MSNThermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz SegmentThermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides ...
Thermo Fisher printed a Sfr410m 0.832% September 2026 at 70bp over Saron, alongside a Sfr315m 1.125% March 2029 at 85bp over; ...
AbbVie, Danaher, Organovo, Thermo Fisher Scientific, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of ...
Thermo Fisher’s release goes on to suggest that it believes it can more than double the profitability of Purification & Filtration under its corporate umbrella, relative to the business’ current ...
Jim Cramer was recently asked about Danaher Corporation (NYSE:DHR) on CNBC. Cramer praised the company’s management and said ...
The young scientists who place today in the senior division will move on to compete at the Texas State Science and ...
The acquisition of Solventum’s Purification & Filtration business will allow Thermo Fisher Scientific to enhance its ...
Genesee Scientific ("Genesee"), a leading manufacturer and distributor of products to the global life science market, has engaged Channel Partnership Services ("CPS"), a life science tools consulting ...
The dPCR & qPCR market size is expected to reach US$ 18.23 billion by 2030 from US$ 8.97 billion in 2022; it is anticipated to record a CAGR of 9.3% during the forecast period. NEW YORK ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report), Amedisys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results